Predicted protein targets (top 4)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MC4R | P32245 | 1/20 | 0.32 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.30 |
| ▸ | TSHR | P16473 | 1/20 | 0.30 |
| ▸ | MCL1 | Q07820 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL3590243 | 0.80 | MC4R (0.33) | MC4RKDM4E | |
| SCHEMBL13881902 | 0.77 | MC4R (0.36) | MC4RKDM4ETSHRMCL1 | |
| SCHEMBL803602 | 0.74 | KDM2B (0.39) | MC4RKDM4ETSHRMCL1 | |
| SCHEMBL23132687 | 0.73 | MC4R (0.36) | MC4RKDM4ETSHRMCL1 | |
| SCHEMBL22130933 | 0.73 | MC4R (0.36) | MC4RKDM4ETSHRMCL1 | |
| SCHEMBL3589255 | 0.72 | KDM2B (0.39) | MC4RKDM4ETSHRMCL1 | |
| SCHEMBL8280536 | 0.72 | MC4R (0.39) | MC4RKDM4E | |
| SCHEMBL23134687 | 0.72 | MC4R (0.39) | MC4RKDM4E | |
| SCHEMBL10233819 | 0.71 | IDO1 (0.37) | MC4RKDM4ETSHRMCL1 | |
| SCHEMBL25700799 | 0.71 | KDM4E (0.40) | MC4RKDM4E |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20100029636-A1 | Lck inhibitors | NOVARTIS AG (CH) | 2010-02-04 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20100029636-A1 | Lck inhibitors | LCK, ZAP70, FYN | MC4R 3945/4885KDM4E 557/4885TSHR 3468/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.